Literature DB >> 12421936

Effect of suppressive DNA on CpG-induced immune activation.

Hiroshi Yamada1, Ihsan Gursel, Fumihiko Takeshita, Jackie Conover, Ken J Ishii, Mayda Gursel, Saoko Takeshita, Dennis M Klinman.   

Abstract

Bacterial DNA and synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs stimulate a strong innate immune response. This stimulation can be abrogated by either removing the CpG DNA or adding inhibitory/suppressive motifs. Suppression is dominant over stimulation and is specific for CpG-induced immune responses (having no effect on LPS- or Con A-induced activation). Individual cells noncompetitively internalize both stimulatory and suppressive ODN. Studies using ODN composed of both stimulatory and suppressive motifs indicate that sequence recognition proceeds in a 5'-->3' direction, and that a 5' motif can block recognition of immediately 3' sequences. These findings contribute to our understanding of the immunomodulatory activity of DNA-based products and the rules that govern immune recognition of stimulatory and suppressive motifs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421936     DOI: 10.4049/jimmunol.169.10.5590

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae.

Authors:  Katherine S Lee; Charles A Scanga; Eric M Bachelder; Quanyi Chen; Clifford M Snapper
Journal:  Cell Immunol       Date:  2007-05-22       Impact factor: 4.868

Review 2.  Synthetic oligonucleotides as modulators of inflammation.

Authors:  Dennis Klinman; Hidekazu Shirota; Debra Tross; Takashi Sato; Sven Klaschik
Journal:  J Leukoc Biol       Date:  2008-04-22       Impact factor: 4.962

3.  Suppressive oligonucleotides inhibit inflammation in a murine model of mechanical ventilator induced lung injury.

Authors:  Julia Scheiermann; Dennis M Klinman
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer.

Authors:  Xinwei Cheng; Qibing Liu; Hong Li; Chen Kang; Yang Liu; Tianqi Guo; Ke Shang; Chengyun Yan; Guang Cheng; Robert J Lee
Journal:  Pharm Res       Date:  2016-11-28       Impact factor: 4.200

5.  Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9.

Authors:  Ana M Avalos; Hidde L Ploegh
Journal:  Eur J Immunol       Date:  2011-09-06       Impact factor: 5.532

Review 6.  Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

7.  Silencing of natural interferon producing cell activation by porcine circovirus type 2 DNA.

Authors:  Isabelle E Vincent; Carole Balmelli; Brian Meehan; Gordon Allan; Artur Summerfield; Kenneth C McCullough
Journal:  Immunology       Date:  2006-10-13       Impact factor: 7.397

Review 8.  Structural requirements and applications of inhibitory oligodeoxyribonucleotides.

Authors:  Robert F Ashman; Petar Lenert
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity.

Authors:  Mirjam Peter; Konrad Bode; Grayson B Lipford; Florian Eberle; Klaus Heeg; Alexander H Dalpke
Journal:  Immunology       Date:  2007-10-23       Impact factor: 7.397

10.  Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation.

Authors:  Takashi Sato; Takeshi Shimosato; W Gregory Alvord; Dennis M Klinman
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.